Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI

McGill University

$4,800.00

Multi-System Neuroimaging Studies of Co-Morbid Addiction & Mental Illness

FY 2008-09

Summary
The primary objective is to create a new research team that unites (i) the Department of Psychiatry / Montreal Neurological Institute neuroimaging group, and (ii) the MUHC¿s Addictions Unit specializing in the treatment of complex, co-morbid mental illness and addiction. This new team will develop a novel research program focused on combined volumetric, connectivity, and multi-tracer PET studies of patients with co-morbid substance use and other neuropsychiatric illnesses. In brief, disturbances to motor and limbic cortico-striatal-thalamic- cortical circuits are thought to increase susceptibility to developing and expressing a wide range of mood, anxiety, impulse-control and substance use disorders. Within these pathways, the key neurotransmitters include dopamine (DA), glutamate (Glu), gamma-aminobutyric acid (GABA), endogenous opioids and serotonin (5-HT). Different combinations of perturbations might predispose individuals to distinct clusters of co-morbid conditions. By exploiting the development of the new imaging methods and evaluating patients both before and after treatment, we expect to obtain an unprecedented characterization of addiction and its diverse co-morbidities; i.e., a detailed multi-system mapping of the relevant neurochemistry and neurocircuitry in health, disease and recovery.
Program
Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
175916
Name
Leyton Marco
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Emerging Team Grant: Co-morbidity of brain disorders and other health problems
Projecttitle
Multi-System Neuroimaging Studies of Co-Morbid Addiction & Mental Illness
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$4,800
Cihrequipment2
$0
Programname2
Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI
Keyworddelim
Co-Morbid Mental Illness; Depression; Magnetic Resonance Imaging; Personality Disorders; Positron Emission Tomograph; Substance Dependence
Abstract
The primary objective is to create a new research team that unites (i) the Department of Psychiatry / Montreal Neurological Institute neuroimaging group, and (ii) the MUHC¿s Addictions Unit specializing in the treatment of complex, co-morbid mental illness and addiction. This new team will develop a novel research program focused on combined volumetric, connectivity, and multi-tracer PET studies of patients with co-morbid substance use and other neuropsychiatric illnesses. In brief, disturbances to motor and limbic cortico-striatal-thalamic- cortical circuits are thought to increase susceptibility to developing and expressing a wide range of mood, anxiety, impulse-control and substance use disorders. Within these pathways, the key neurotransmitters include dopamine (DA), glutamate (Glu), gamma-aminobutyric acid (GABA), endogenous opioids and serotonin (5-HT). Different combinations of perturbations might predispose individuals to distinct clusters of co-morbid conditions. By exploiting the development of the new imaging methods and evaluating patients both before and after treatment, we expect to obtain an unprecedented characterization of addiction and its diverse co-morbidities; i.e., a detailed multi-system mapping of the relevant neurochemistry and neurocircuitry in health, disease and recovery.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Leyton, Marco; Gill, Kathryn J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $4,800~ $0~